I really enjoyed learning about the Cole‐Reagins Registry for Sinonasal Cancer (CORSICA) program, which was the topic of a small conference/discussion group here at Penn this past weekend, hosted by Drs. Jim Palmer and Nithin Adappa from the Division of Rhinology in our department. CORSICA is a prospective, longitudinal, observational registry based on a secure cloud‐based computing platform designed to prospectively capture data of sinonasal malignancies, including patient characteristics, treatment, quality of life, and oncologic outcomes. This is a very promising initiative to combine observations and learn more about rare types of sinonasal cancer to generate better empirical data and determine more effective therapies. It was a very interesting seminar and there were some great discussions not only about CORSICA itself but also about harnessing patient data to identify biomarkers and therapeutic targets.